OUR PRODUCTS

MOBILE APPS

GENERAL INFO

PYPD

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

PolyPid (PYPD) Earnings Date & Reports

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PYPD is expected to report earnings to fall 57.69% to -33 cents per share on November 05

Q3'25

Est.

$-0.33

Q2'25

Missed

by $0.21

Q1'25

Beat

by $0.22

Q4'24

Missed

by $0.22

Q3'24

Missed

by $0.22

The last earnings report on August 13 showed earnings per share of -77 cents, missing the estimate of -56 cents. With 62.48K shares outstanding, the current market capitalization sits at 54.85M.

View a ticker or compare two or three

Compare

PYPD

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For PYPD
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PYPD showed earnings on August 13, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a clinical stage biopharmaceutical company focusing on the development, manufacture, and commercialization of administered therapies to improve surgical outcomes

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

18 Hasivim Street

Phone

+972 747195700

Employees

Web

https://www.polypid.com